BeesFree (OTCQB: BEES) is developer of an innovative composite food supplement for honeybees to minimize Colony Collapse Disorder (CCD). Similar to human nutritional supplements by companies like GNC Holdings Inc. (NYSE: GNC) or Schiff Nutrition International Inc. (NYSE: SHF), these supplements help prevent disease in bees – including a very deadly one.
To syndicate this article, or for more information, please contact us online or call (406) 862-5400.
Colony Collapse Disorder
Colony Collapse Disorder (CCD) is a mysterious phenomenon where worker bees from a beehive suddenly disappear. While these disappearances have happened in the past, a dramatic rise in CCD incidents during late 2006 in the U.S. led to heightened concern. Moreover, there is widespread disagreement about the causes of CCD, which makes a solution hard to find.
In 2010, the U.S. Department of Agriculture estimated that some 34% of the honeybee population was lost to CCD, while similar problems have been reported around the world in Europe, Latin America and Australia. Germany alone was rumored to have lost around 40% of its honeybee colonies, though there was no scientific confirmation of that figure.
According to a recent Reuters report, bees are worth an estimated $212 billion to the world economy. A worsening loss rate of between 20% and 30% could therefore be devastating to the world economy if it’s not solved.
BeesFree has developed an innovative composite food supplement that has been shown to strengthen a honeybee’s immune system thereby allowing it to survive more environmental toxins and more stress. By combining a simple dispenser with a proprietary water soluble preparation, the company’s food supplement contains antimicrobial agents, anti-neonicotinoid compounds, nutrients and antioxidants capable of fighting the causes of CCD.
“BeesVita Plus is composed of scientifically-engineered, natural components proven to contrast neonicotinoids’ side effects in honeybees,” said inventor Dr. Francesca del Vacchio in a recent press release. “A three year study conducted in Italy’s agriculturally-rich Tuscany region, where CCD has ravaged billions of honeybees, concluded that colonies fed BeesVita Plus not only survived but thrived… populations increased by as much as 50%… compared to a 40% decline.”
These results have led to the company’s early commercial ventures in Europe. Recently, the firm announced that it received its first order for delivery in Italy valued at $250,000 for 4,500 liters of BeesVita Plus. The company also received an order from Slovakia valued at $190,000 for 3,500 liters of the formula to have curb incidents of CCD. With a consumable product, these orders could be the first of many in its early stage rollout.
Solid Growth Play
BeesFree represents a unique play on a growing worldwide epidemic affecting the $212 billion bee industry. With a proven solution to CCD in the early stages of commercialization, the company is well positioned for growth investors looking for a unique play on an epidemic of increasing global concern.
For more information, please see the following resources: